c-Abl–p38α signaling plays an important role in MPTP-induced neuronal death
Authors:
Open Access
- 30 October 2015
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 23 (3) , 542-552
Abstract
Oxidative stress is a major cause of sporadic Parkinson’s disease (PD). Here, we demonstrated that c-Abl plays an important role in oxidative stress-induced neuronal cell death. C-Abl, a nonreceptor tyrosine kinase, was activated in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced acute PD model. Conditional knockout of c-Abl in neurons or treatment of mice with STI571, a c-Abl family kinase inhibitor, reduced the loss of dopaminergic neurons and ameliorated the locomotive defects induced by short-term MPTP treatment. By combining the SILAC (stable isotope labeling with amino acids in cell culture) technique with other biochemical methods, we identified p38α as a major substrate of c-Abl both in vitro and in vivo and c-Abl-mediated phosphorylation is critical for the dimerization of p38α. Furthermore, p38α inhibition mitigated the MPTP-induced loss of dopaminergic neurons. Taken together, these data suggested that c-Abl–p38α signaling may represent a therapeutic target for PD.Keywords
This publication has 31 references indexed in Scilit:
- Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease ModelPLOS ONE, 2013
- Regulation of Neuronal Cell Death by c-Abl-Hippo/MST2 Signaling PathwayPLOS ONE, 2012
- c-Abl in Neurodegenerative DiseaseJournal of Molecular Neuroscience, 2011
- Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's DiseaseJournal of Neuroscience, 2011
- Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective functionProceedings of the National Academy of Sciences, 2010
- c-Jun N-terminal Kinase Enhances MST1-mediated Pro-apoptotic Signaling through Phosphorylation at Serine 82Journal of Biological Chemistry, 2010
- T Cell Receptor-mediated Activation of p38α by Mono-phosphorylation of the Activation Loop Results in Altered Substrate SpecificityJournal of Biological Chemistry, 2009
- Diagnosis and treatment of Parkinson disease: molecules to medicineJournal of Clinical Investigation, 2006
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated EffluxThe Journal of Pharmacology and Experimental Therapeutics, 2003